Curanex Pharmaceuticals Inc
Last updated September 27, 2026
Organization details
- Legal name
- Curanex Pharmaceuticals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Jericho
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CURX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002025942
- EIN
- 83-0741390
Board of directors
-
Helen Hong Hsu · DirectorSince 2025
-
Huijuan Zhong · Director · Chief Science OfficerSince 2025
-
Jun Liu · Director · CEO and PresidentSince 2025
-
Xiaohui Hao · DirectorSince 2025
-
Yong Yan · DirectorSince 2025
Chief executives
Jun Liu
· CEO and President
Since August 2025
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Curanex Pharmaceuticals Inc
Who is the CEO of Curanex Pharmaceuticals Inc?
Jun Liu has been Curanex Pharmaceuticals Inc's CEO and President since August 2025.
How many directors are on Curanex Pharmaceuticals Inc's board?
Curanex Pharmaceuticals Inc's board has 5 directors: Helen Hong Hsu, Huijuan Zhong, Jun Liu, Xiaohui Hao and Yong Yan.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="curanex-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.